RTCT raises hard questions about sponsor liability, blinding integrity, DSMB overlap, and AI accountability that the industry hasn’t yet resolved. Both sides of that ledger deserve honest consideration.
- Pharma's Digital Transformation: Where It's Really At
- How AI Is Changing Clinical Trial Design, Not Just Speed
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- What Clinical Analytics Solutions Are Shaping Clinical Research
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Recruitment Capabilities Delivering In Today's Trial Landscape
Recruitment demands diverse capabilities — AI, data analytics, stakeholder engagement, operational excellence — to meet complex protocols and deliver high-quality patient enrollment outcomes.
-
Navigating The Evolving Regulatory And Data Landscape
Explore how real-world evidence is reshaping clinical research and learn why precision and innovation are key to staying ahead in this evolving landscape.
-
Empowering Clinical Trial Sponsors With Analytics
Explore data challenges faced by sponsors, the underlying problems driving those challenges, and flexible processes and solutions designed to help overcome them.
-
You Don't Have To Digitize Everything, You Just Have To Start
Feeling left behind by the sudden digitization of clinical trials? Decentralized clinical trials can be adapted to best serve the patient population, condition, or therapy you’re investigating.
-
Revolutionizing Pediatric Clinical Trials With ePRO And eConsent
Digital tools like ePRO and eConsent are essential in addressing pediatric trial challenges such as the diverse participant ages and family involvement, which impact retention and data quality.
-
FDA Pushes For Patient Voice: ePRO In Oncology Trials
FDA urges sponsors and CROs to include patient voices in oncology trials. Discover why it matters and how to start integrating this approach.
-
Navigating Audit Trail Data Regulations And Accessibility Changes
Data is the single most important thing in a clinical trial. Leverage the power of clinical trial data with effective utilization and access in a changing regulatory landscape.
-
eSource vs. EDC: Reimagining Your Clinical Trials
Explore how an eSource approach to clinical trial data can reduce site burden, eliminate double data entry, minimize queries, and enhance remote monitoring.
-
How To Make eConsent Accessible Across Diverse Populations
Accessible eConsent removes language, literacy, disability, and tech barriers, improving comprehension, equity, compliance, participant trust, inclusive enrollment, and data quality.
-
Top 10 Challenges And Solutions For Decentralized Clinical Trials
Decentralized clinical trials are reshaping research, but what are the biggest roadblocks to their full potential? We delve into the top 10 challenges and the cutting-edge solutions emerging.
RECENT NEWSLETTERS
- 05.28.26 -- FDA's Elsa AI Shift, RTCT Rules, And RWE That Works
- 05.21.26 -- AI, HEOR, And Hidden Costs Reshaping Clinical Trials
- 05.14.26 -- AI, RWE, And The Systems Breaking Clinical Trials
- 05.07.26 -- How AI, ICH E6(R3) & RWD Are Reshaping Clinical Trials
- 05.02.26 -- Best Of April: AI In Clinical Trials — What Working